| RS1553137699 |
PCSK9
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1553138299 |
SZT2
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1553138869 |
SZT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS1553141017 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS1553141680 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553141686 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553141706 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553141707 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553142428 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553142436 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A2 |
| RS1553143142 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1553143165 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553143741 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS1553143791 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553143852 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1553143890 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553144066 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553144086 |
MFN2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553145402 |
MFN2
|
Health Risk |
Likely pathogenic |
Hereditary motor and sensory neuropathy with optic atrophy, Hereditary motor and sensory neuropathy with optic atrophy |
| RS1553145409 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553145891 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553146165 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1553146551 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1553146559 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1553146806 |
PINK1;PINK1-AS
|
Health Risk |
Likely pathogenic |
— |
| RS1553148514 |
NFIA
|
Health Risk |
Conflicting classifications of pathogenicity |
NFIA-related disorder, Inborn genetic diseases |
| RS1553149167 |
NFIA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Brain malformations with or without urinary tract defects |
| RS1553149182 |
NFIA
|
Health Risk |
Pathogenic |
NFIA-related disorder, Brain malformations with or without urinary tract defects |
| RS1553149185 |
NFIA
|
Health Risk |
Pathogenic |
Brain malformations with or without urinary tract defects, Inborn genetic diseases |
| RS1553149202 |
NFIA
|
Health Risk |
Likely pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS1553149206 |
NFIA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553149467 |
ARID1A
|
Health Risk |
association |
Colorectal cancer, Colorectal cancer |
| RS1553150995 |
AK2
|
Health Risk |
Pathogenic |
Reticular dysgenesis, Reticular dysgenesis |
| RS1553151177 |
AK2
|
Health Risk |
Pathogenic |
Reticular dysgenesis, Reticular dysgenesis |
| RS1553151208 |
B3GALT6
|
Health Risk |
Likely pathogenic |
— |
| RS1553151294 |
B3GALT6
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia with joint laxity, type 1 |
| RS1553152590 |
ARID1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1553152989 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis 2 |
| RS1553153130 |
ARID1A
|
Health Risk |
Pathogenic |
— |
| RS1553153135 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1553153243 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 2, Leber congenital amaurosis 2 |
| RS1553153291 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1553153365 |
HNRNPR
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities |
| RS1553153399 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553153597 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS1553153669 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS1553153770 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553153771 |
ARID1A
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome, Coffin-Siris syndrome |
| RS1553153783 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS1553154062 |
AGO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental abnormality |
| RS1553154069 |
AGO1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures |
| RS1553154130 |
RERE
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS1553154132 |
RERE
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neurodevelopmental disorder with or without anomalies of the brain |
| RS1553155565 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553155581 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS1553155778 |
RERE
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553155823 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553155843 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553155880 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553155885 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1553155887 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1553155891 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553155900 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1553155973 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1553155982 |
SLC2A1
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1553155986 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, GLUT1 deficiency syndrome 1 |
| RS1553156002 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1553156047 |
SLC2A1
|
Health Risk |
Pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, Childhood onset GLUT1 deficiency syndrome 2 |
| RS1553156051 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1553156053 |
SLC2A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, GLUT1 deficiency syndrome 1 |
| RS1553156069 |
SLC2A1
|
Health Risk |
Pathogenic |
Encephalopathy due to GLUT1 deficiency, Encephalopathy due to GLUT1 deficiency |
| RS1553156086 |
SLC2A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Epilepsy |
| RS1553156106 |
RHCE
|
Health Risk |
Pathogenic |
RH-NULL, AMORPH TYPE |
| RS1553156146 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS1553156154 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553156161 |
SLC2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553156199 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1553156203 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS1553156882 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553156884 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553156894 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553157428 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1553157912 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553157935 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome, Encephalopathy due to GLUT1 deficiency |
| RS1553158393 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553158517 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553158679 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553158807 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553158947 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS1553158952 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553159009 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553159175 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553159284 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1553159383 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553159575 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553159581 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553159719 |
TARDBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS1553159739 |
TARDBP
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 10, Amyotrophic lateral sclerosis type 10 |
| RS1553159753 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1553159764 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |